ATE384054T1 - Substituierte benzoxazinones und ihre verwendung - Google Patents
Substituierte benzoxazinones und ihre verwendungInfo
- Publication number
- ATE384054T1 ATE384054T1 AT03789002T AT03789002T ATE384054T1 AT E384054 T1 ATE384054 T1 AT E384054T1 AT 03789002 T AT03789002 T AT 03789002T AT 03789002 T AT03789002 T AT 03789002T AT E384054 T1 ATE384054 T1 AT E384054T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted benzoxazinones
- benzoxazinones
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
- C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42494602P | 2002-11-08 | 2002-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE384054T1 true ATE384054T1 (de) | 2008-02-15 |
Family
ID=32312902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03789002T ATE384054T1 (de) | 2002-11-08 | 2003-11-04 | Substituierte benzoxazinones und ihre verwendung |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7141562B2 (de) |
| EP (1) | EP1562918B1 (de) |
| JP (1) | JP4401297B2 (de) |
| KR (1) | KR100683361B1 (de) |
| CN (1) | CN100390157C (de) |
| AR (1) | AR042002A1 (de) |
| AT (1) | ATE384054T1 (de) |
| AU (1) | AU2003293653B2 (de) |
| BR (1) | BR0315302A (de) |
| CA (1) | CA2505334A1 (de) |
| DE (1) | DE60318733T2 (de) |
| DK (1) | DK1562918T3 (de) |
| ES (1) | ES2298609T3 (de) |
| GT (1) | GT200300241A (de) |
| HR (1) | HRP20050390A2 (de) |
| IL (1) | IL168343A (de) |
| MX (1) | MXPA05004758A (de) |
| MY (1) | MY136824A (de) |
| NO (1) | NO20052074L (de) |
| NZ (1) | NZ539508A (de) |
| PA (1) | PA8587501A1 (de) |
| PE (1) | PE20040828A1 (de) |
| PL (1) | PL377770A1 (de) |
| PT (1) | PT1562918E (de) |
| RU (1) | RU2328490C2 (de) |
| TW (1) | TWI285639B (de) |
| WO (1) | WO2004041792A1 (de) |
| ZA (1) | ZA200503248B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1408976B3 (de) * | 2001-07-20 | 2010-08-25 | Psychogenics Inc. | Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten |
| US7452888B2 (en) | 2002-03-27 | 2008-11-18 | Glaxo Group Limited | Quinoline derivatives and their use as 5-ht6 ligands |
| MXPA06000795A (es) | 2003-07-22 | 2006-08-23 | Arena Pharm Inc | Derivados de diaril y arilheteroaril urea como moduladores del receptor 5-ht2a de serotonina utiles para la profilaxis y tratamiento de desordenes relacionados con el mismo. |
| KR100827915B1 (ko) | 2003-12-09 | 2008-05-07 | 에프. 호프만-라 로슈 아게 | 벤즈옥사진 유도체 및 그의 용도 |
| AU2005291542B2 (en) * | 2004-09-30 | 2010-11-04 | F. Hoffmann-La Roche Ag | Compositions and methods for treating cognitive disorders |
| US7713954B2 (en) * | 2004-09-30 | 2010-05-11 | Roche Palo Alto Llc | Compositions and methods for treating cognitive disorders |
| CA2615007A1 (en) | 2005-07-13 | 2007-01-18 | F. Hoffmann-La Roche Ag | Benzimidazole derivatives as 5-ht6,5-ht24 |
| US20080275058A1 (en) * | 2005-09-15 | 2008-11-06 | Korea Research Institute Of Chemical Technology | N-Substituted-1H-Quinoline-2,4-Diones, Preparation Method Thereof, And Pharmaceutical Composition Containing The Same |
| TWI385161B (zh) * | 2006-02-02 | 2013-02-11 | Mitsubishi Tanabe Pharma Corp | 含氮雜雙環化合物 |
| JP2009541423A (ja) * | 2006-06-23 | 2009-11-26 | ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ | コリンエステラーゼ阻害剤と５‐ｈｔ６レセプター親和性の化合物との組合せ |
| EP2508177A1 (de) | 2007-12-12 | 2012-10-10 | Glaxo Group Limited | Kombinationen mit 3-phenylsulfonyl-8-piperazinyl-1yl-chinolin |
| US20110021538A1 (en) | 2008-04-02 | 2011-01-27 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
| ITMI20131782A1 (it) * | 2013-10-25 | 2015-04-26 | Dipharma Francis Srl | Procedimento per la preparazione di un agonista della trombopoietina |
| RU2017145976A (ru) | 2015-06-12 | 2019-07-15 | Аксовант Сайенсиз Гмбх | Производные диарил- и арилгетероарилмочевины, применимые для профилактики и лечения нарушения поведения во время REM-фазы сна |
| EP3322415A4 (de) | 2015-07-15 | 2019-03-13 | Axovant Sciences GmbH | Diaryl- und arylheteroaryl-harnstoff-derivate als modulatoren des 5-ht2a-serotoninrezeptors zur prophylaxe und behandlung von halluzinationen im zusammenhang mit einer neurogenerativen erkrankung |
| RU2624978C2 (ru) * | 2015-07-27 | 2017-07-11 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежский государственный медицинский университет им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации | Способ лечения умеренного когнитивного снижения |
| MX2020001311A (es) * | 2017-08-07 | 2020-03-20 | Suven Life Sciences Ltd | Compuestos de fluoropiperidina como antagonistas del receptor 5-hidroxitriptamina 6 puro. |
| CN111559990B (zh) * | 2020-05-29 | 2021-03-09 | 四川大学华西医院 | 一种小分子噁噻嗪类衍生物及其应用 |
| CN112047898A (zh) * | 2020-10-14 | 2020-12-08 | 兰州大学 | 一种苯并[c][1,2]噁嗪骨架类新化合物及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU784769A3 (ru) * | 1977-03-17 | 1980-11-30 | Шел Интернэшнл Рисерч Маатсхаппии Б.В. (Фирма) | Способ получени бензоксазинкарбоксамидов |
| EP0189612B1 (de) * | 1984-12-21 | 1992-11-04 | Duphar International Research B.V | Arzneimittel mit psychotroper Wirkung |
| AU605304B2 (en) * | 1987-06-22 | 1991-01-10 | Nihon Tokushu Nayaku Seizo K.K. | Benzo-fused cyclic compounds |
| FR2667068B1 (fr) * | 1990-09-26 | 1994-09-09 | Adir | Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5955470A (en) * | 1991-06-11 | 1999-09-21 | Merrell Pharmaceuticals, Inc. | Derivatives of amide analogs of certain methano bridged quinolizines |
| NZ331860A (en) | 1996-03-29 | 2000-04-28 | Duphar Int Res | Piperazine and piperidine compounds with affinity for both dopamine D2 and seratonin 5-HT1A receptors |
| ATE253058T1 (de) * | 1997-09-02 | 2003-11-15 | Duphar Int Res | Piperidin- und piperazin derivate als 5-ht1- rezeptor-agonisten |
| US7067513B1 (en) * | 1999-08-23 | 2006-06-27 | Solvay Pharmaceuticals B.V. | Phenylpiperazines |
| AU2001236606A1 (en) | 2000-02-01 | 2001-08-14 | Cor Therapeutics, Inc. | 3,4-dihydro-2h-benzo(1,4)oxazine inhibitors of factor xa |
| WO2001072725A1 (en) | 2000-03-24 | 2001-10-04 | Cor Therapeutics, Inc. | BICYCLIC SULFONYL AMINO INHIBITORS OF FACTOR Xa |
| DE10031391A1 (de) | 2000-07-03 | 2002-02-07 | Knoll Ag | Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie |
| BR0114881A (pt) * | 2000-10-26 | 2003-09-30 | Smithkline Beecham Plc | Derivados de benzoxazinona, sua preparação e uso |
| CA2456250A1 (en) * | 2001-08-10 | 2003-02-20 | F. Hoffmann-La Roche Ag | Arylsulfonyl derivatives with 5-ht6 receptor affinity |
| JP4307377B2 (ja) * | 2002-05-13 | 2009-08-05 | エフ．ホフマン−ラ ロシュ アーゲー | ５−ｈｔ６モジュレーターとしてのベンゾオキサジン誘導体及びそれらの使用 |
-
2003
- 2003-11-04 PL PL377770A patent/PL377770A1/pl unknown
- 2003-11-04 AU AU2003293653A patent/AU2003293653B2/en not_active Ceased
- 2003-11-04 CA CA002505334A patent/CA2505334A1/en not_active Abandoned
- 2003-11-04 HR HR20050390A patent/HRP20050390A2/xx not_active Application Discontinuation
- 2003-11-04 DE DE60318733T patent/DE60318733T2/de not_active Expired - Lifetime
- 2003-11-04 ES ES03789002T patent/ES2298609T3/es not_active Expired - Lifetime
- 2003-11-04 MX MXPA05004758A patent/MXPA05004758A/es active IP Right Grant
- 2003-11-04 WO PCT/EP2003/012278 patent/WO2004041792A1/en not_active Ceased
- 2003-11-04 NZ NZ539508A patent/NZ539508A/en not_active IP Right Cessation
- 2003-11-04 EP EP03789002A patent/EP1562918B1/de not_active Expired - Lifetime
- 2003-11-04 KR KR1020057008044A patent/KR100683361B1/ko not_active Expired - Fee Related
- 2003-11-04 RU RU2005117965/04A patent/RU2328490C2/ru not_active IP Right Cessation
- 2003-11-04 PT PT03789002T patent/PT1562918E/pt unknown
- 2003-11-04 JP JP2004549101A patent/JP4401297B2/ja not_active Expired - Fee Related
- 2003-11-04 DK DK03789002T patent/DK1562918T3/da active
- 2003-11-04 AT AT03789002T patent/ATE384054T1/de active
- 2003-11-04 CN CNB2003801053862A patent/CN100390157C/zh not_active Expired - Fee Related
- 2003-11-04 BR BR0315302-9A patent/BR0315302A/pt not_active Application Discontinuation
- 2003-11-04 TW TW092130842A patent/TWI285639B/zh active
- 2003-11-05 PA PA20038587501A patent/PA8587501A1/es unknown
- 2003-11-05 PE PE2003001114A patent/PE20040828A1/es not_active Application Discontinuation
- 2003-11-06 US US10/702,302 patent/US7141562B2/en not_active Expired - Fee Related
- 2003-11-06 GT GT200300241A patent/GT200300241A/es unknown
- 2003-11-07 MY MYPI20034282A patent/MY136824A/en unknown
- 2003-11-07 AR ARP030104100A patent/AR042002A1/es unknown
-
2005
- 2005-04-21 ZA ZA200503248A patent/ZA200503248B/en unknown
- 2005-04-27 NO NO20052074A patent/NO20052074L/no not_active Application Discontinuation
- 2005-05-02 IL IL168343A patent/IL168343A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60314600D1 (de) | O-cyclopropyl-carboxanilide und ihre verwendung als fungizide | |
| ATE424202T1 (de) | Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung | |
| DE60309874D1 (de) | Malonsäuerenitril-verbindungen und ihre verwendung als pestizide | |
| DE60317093D1 (de) | Chinolin-; isochinolin- und chinazolinoxyalkylamide und ihre verwendung als fungizide | |
| DE50207849D1 (de) | Substituierte 2-oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre verwendung | |
| ATE533508T1 (de) | Cripto-blockierende antikörper und ihre verwendung | |
| ATE479437T1 (de) | Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung | |
| DE50115561D1 (de) | Spektralphotometer und Verwendung desselben | |
| DE60318733D1 (de) | Substituierte benzoxazinones und ihre verwendung | |
| ATE356807T1 (de) | 4-aminopicolinate und ihre verwendung als herbizide | |
| ATE409700T1 (de) | Cannabinoid rezeptor-liganden und ihre verwendung | |
| DE60326611D1 (de) | N und dergleichen | |
| EP1746902A4 (de) | Multilektin-affiniätschromatografie und verwendung dafür | |
| ATE428710T1 (de) | Substituierte phenylaminothiazole und ihre verwendung | |
| DE60321958D1 (de) | Indazolderivate und ihre verwendung als crf antagonisten | |
| DE60334292D1 (de) | Ylenverbundemulsionszusammensetzung und verwendung davon | |
| DE602004010426D1 (de) | Mikrobizide zusammensetzungen und ihre verwendung | |
| ATE329906T1 (de) | Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren | |
| ATE419366T1 (de) | Tyra-gene und ihre verwendung | |
| ATE423117T1 (de) | Heterocyclische 7-aminoalkylidenylchinolone und - naphthyridone | |
| ATE362469T1 (de) | 2,7-disubstituierteindole und ihre verwendung als 5-ht6 modulatoren | |
| DE60230162D1 (de) | Polymerisate und ihre verwendung | |
| DE60311598D1 (de) | Naphthyridin-derivate und ihre verwendung als fungizide | |
| DE60321372D1 (de) | 3-phenylpyridoindolderivate, ihre herstellung und verwendung | |
| DE50008549D1 (de) | Triazolotriazinone und ihre verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1562918 Country of ref document: EP |